Geriatric Medicines Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Geriatric Medicines Market is expected to grow at a CAGR of 6% during the forecast period 2022-2028.

Geriatrics, also known as geriatrics, is a branch of medicine concerned with the prevention, cure, clinical and social aspects of most diseases for adults 65 years of age and older. Without proper consideration, a mature body is permanently invincible, and elderly patients are particularly vulnerable to neurological, cardiovascular and respiratory diseases. Geriatric medicines are an important part of therapeutic science providing modified diagnostics and treatment options for the elderly, and a corresponding market is thriving.

Market Segments

By Therapeutic

• Analgesic
• Antihypertensive
• Statins
• Antidiabetic
• Proton Pump Inhibitor
• Anticoagulant
• Antipsychotic and Antidepressant

By Application

• Cardiovascular
• Arthritis
• Diabetes
• Neurological
• Cancer
• Osteoporosis
• Respiratory

Key Players

• Pfizer, Inc.
• Merck & Co., Inc.
• AstraZeneca
• Bristol-Myers Squibb Company
• Novartis AG
• Sanofi S.A.
• GlaxoSmithKline plc Eli Lilly and Company
• Abbott Laboratories
• Boehringer Ingelheim GmbH

Scope of the Report

The research study analyzes the global Geriatric Medicines industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Geriatric Medicines Market Report

1. What was the Geriatric Medicines Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Geriatric Medicines Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Geriatric Medicines Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.